跳至主要内容
临床试验/CTRI/2024/08/072641
CTRI/2024/08/072641尚未招募3 期

A randomized clinical trial to evaluate the combined effect of yavas kalpana and yoga therapy in management of prediabetes.

Institute for Ayurved Studies And Research,Shri Krishna Ayush University, Kurkshetra1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年9月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
To prevent the patient from landing into type 2 diabetes mellitus.

研究概览

简要总结

The term  Pre diabetes or intermediate hyperglycemia is strong risk factor for diabetes mellitus.In Ayurveda Pooravroopas of Pramehaare valuable signs and symptoms to predict the disease in early stage and to check its progression towards Madhumeha and its complication by modification of lifestyle .The purpose of this clinical study to evaluate efficacy of Yava’s Kalpanaand Yoga therapy on Prediabetes.The study will be conducted in three groups each group comprises 30 patients.Group A receive Yogatherapy for 35-40 min once in a day. Group B receiveYavakalpana twice a day. Group C receive bothYava kalpanaand Yoga therapy twice a day.Study time period is one month.Patient’s sign and symptoms will be assesed by subjective and objective parameters.Informed consent will be taken before trial.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient sign consent form.
  • BMI greater than 23 kilogram per metersquare.
  • Impaired fasting glucose from 100 miligram per decilitre to 126 miligram per decilitre.
  • 4.Hba1c range 5.7 to 6.4 percent.

排除标准

  • 1.Age below 35 and above 55 years.
  • Patients with history of any chronic disorder or any health challenging diseases.
  • Patients having Impaired fasting glucose less than 100mg/dl and greater than 126mg/dl.
  • Patients having Hba1c Range more than 6.4% and less than 5.7%
  • Patients having hypertension, neuromuscular disease,disc prolapse,osteoarthritisand any type of hernia.
  • Drugs known to influence glycemic status like steroids,antipschychotic,birth control pills,HIV medicines.

结局指标

主要结局

To prevent the patient from landing into type 2 diabetes mellitus.

时间窗: 0,15,30 days and post treatment follow up

次要结局

  • To control Hba1c level(Pre and post treatment)

研究者

发起方
Institute for Ayurved Studies And Research,Shri Krishna Ayush University, Kurkshetra
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Manisha

Institue for ayurved studies and research,faculty of ayurved kurukshetra.

研究点 (1)

Loading locations...

相似试验